Citation: O. Koch et al., EFFECTS OF CONVENTIONAL ANTIEPILEPTIC DRUGS ON GABA AND GLUTAMATE RECEPTORS, European journal of neuroscience, 10, 1998, pp. 2042-2042
Authors:
FREUND M
HEUSSNER P
HILD F
NOWAK R
GROTEMETKE A
DIEDRICH H
KOCH O
OTREMBA B
VONWUSSOW P
KLEINE HD
MERAN J
LINK H
HINRICHS HF
BALLEISEN L
FONATSCH C
POLIWODA H
Citation: M. Freund et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA - A DECADE OF EXPERIENCE, Medizinische Klinik, 91, 1996, pp. 18
Authors:
ZEILICOFF R
AMEIGEIRAS B
OJEDA E
GRUNBAUM S
GENERO M
CAPPELLETTI C
TIELLI G
ISLA RR
ROATTA R
KOCH O
CRAVERO A
BACCARO JC
Citation: R. Zeilicoff et al., DETECTION OF RNA-HEPATITIS-C VIRUS IN LIVER, PLASMA AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN INTERFERON-TREATED PATIENTS - CLINICAL IMPORTANCE, Hepatology, 24(4), 1996, pp. 120-120
Citation: Mo. Tapia et al., LIVER NECROSIS INDUCED BY WEDELIA-GLAUCA IN RATS - A LIGHT AND ELECTRON-MICROSCOPY STUDY, Veterinary and human toxicology, 38(1), 1996, pp. 10-14
Citation: T. Seck et al., INFLUENCE OF GLYCOPROTEIN-B, GLYCOPROTEIN-C AND GLYCOPROTEIN-D ON THECONVERSION OF VIRUS-TO-CELL ATTACHMENT FROM HEPARIN SENSITIVITY TO RESISTANCE, Acta virologica, 40(4), 1996, pp. 179-185
Citation: C. Muller et al., LOSS IN PROTEIN-PHOSPHORYLATION AND APOPTOSIS ARE INDUCED BY INHIBITION OF MEVALONATE PATHWAY IN BCR-ABL POSITIVE K562 LEUKEMIC-CELL LINE, Experimental hematology, 23(8), 1995, pp. 826-826
Authors:
SPITZER M
MAIER S
HARIG S
HIMMELSBACH U
HORZ P
KOCH O
Citation: M. Spitzer et al., LANGUAGE, SPREADING ACTIVATION, LATERALITY, AND SCHIZOPHRENIC THOUGHT-DISORDER, Schizophrenia research, 11(2), 1994, pp. 153-153
Authors:
MARTIN I
AGUIRRE F
GROSMAN G
SARCHI MI
KOCH O
Citation: I. Martin et al., GLUCOCORTICOID RESPONSE AND ADRENAL LIPID-PEROXIDATION IN RATS SUBMITTED TO CHRONIC HYPOBARIC HYPOXIA, ARCH I PHYS, 101(3), 1993, pp. 173-177
Authors:
FREUND M
HILD F
GROTEMETKE A
NOWAK R
OTREMBA B
WORMANN B
KOCH O
DOHMEN M
KLEINE HD
LINK H
HIDDEMANN W
HINRICHS F
BALLEISEN L
FONATSCH C
POLIWODA H
Citation: M. Freund et al., COMBINATION OF CHEMOTHERAPY AND INTERFERON ALFA-2B IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA, Seminars in hematology, 30(3), 1993, pp. 11-13